CardioPolymers Overview
- Year Founded
-
2002
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
CardioPolymers General Information
Description
Developer of an implantable device for treating congestive heart failure. The company provides biocompatible polymer implant therapies to handle chronic heart failure, mitral valve regurgitation, and post-operative atrial fibrillation.
Contact Information
Website
www.cardiopolymers.comCorporate Office
- 26051 Merit Circle
- Suite 104
- Laguna Hills, CA 92653
- United States
Corporate Office
- 26051 Merit Circle
- Suite 104
- Laguna Hills, CA 92653
- United States
CardioPolymers Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 02-Jun-2010 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 20-Apr-2010 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C) | 22-Jul-2009 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 05-Sep-2008 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 17-Nov-2006 | Completed | Startup | |||
| 2. Early Stage VC (Series A) | 01-Jun-2004 | $2.6M | $3.2M | Completed | Startup | |
| 1. Early Stage VC (Series A1) | 09-Sep-2002 | $600K | $600K | Completed | Startup |
CardioPolymers Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 2,888,889 | $0.001000 | $0.14 | $1.8 | $1.8 | 1x | $1.8 | 3.41% |
| Series A1 | 625,000 | $0.001000 | $0.1 | $1.2 | $1.2 | 1x | $1.2 | 0.74% |
CardioPolymers Patents
CardioPolymers Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20140275774-A1 | Delivery catheter | Inactive | 15-Mar-2013 | ||
| WO-2014145105-A2 | Delivery catheter | Inactive | 15-Mar-2013 | ||
| WO-2014145105-A3 | Delivery catheter | Inactive | 15-Mar-2013 | ||
| US-20140275773-A1 | Delivery catheter for injecting a substrate into a tissue | Inactive | 15-Mar-2013 | ||
| AU-2009289484-A1 | Apparatus and method for capsule formation in tissue | Active | 05-Sep-2008 | A61M25/1029 |
CardioPolymers Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Domain Associates | Venture Capital | Minority | ||
| Fjord Ventures | Venture Capital | Minority | ||
| Johnson & Johnson JJDC | Corporate Venture Capital | Minority | ||
| Morgenthaler | Venture Capital | Minority | ||
| Saints Capital | Secondary Buyer | Minority |
CardioPolymers FAQs
-
When was CardioPolymers founded?
CardioPolymers was founded in 2002.
-
Where is CardioPolymers headquartered?
CardioPolymers is headquartered in Laguna Hills, CA.
-
What industry is CardioPolymers in?
CardioPolymers’s primary industry is Therapeutic Devices.
-
Is CardioPolymers a private or public company?
CardioPolymers is a Private company.
-
What is CardioPolymers’s current revenue?
The current revenue for CardioPolymers is .
-
How much funding has CardioPolymers raised over time?
CardioPolymers has raised $26.1M.
-
Who are CardioPolymers’s investors?
Domain Associates, Fjord Ventures, Johnson & Johnson JJDC, Morgenthaler, and Saints Capital are 5 of 6 investors who have invested in CardioPolymers.
-
When was CardioPolymers acquired?
CardioPolymers was acquired on 02-Jun-2010.
-
Who acquired CardioPolymers?
CardioPolymers was acquired by LoneStar Heart.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process